Filed before 2025Filed 29 December 2022
Optofluidics, Inc. has sold $7M so far
Optofluidics, Inc., a biotech company based in Burlingame, CA, has sold $7M so far in its equity round, according to a filing dated 29 December 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 29 December 2022
- First filed
- 11 July 2022
- Round
- Equity round (amended filing)
- Amount sold
- $7M
- Offering size
- $7M
- Investors so far
- 11
- Based in
- Burlingame, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 44% of the 1,764 tracked raises with an amount filed in 2022, and than 39% of the 142 in biotech.
Optofluidics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 29 Dec 2022 | Amended filing | $7M | This raise |
| 11 Jul 2022 | New filing | $6M | This raise |
| 13 Apr 2020 | New filing | $6.74M | Another raise |
More with BroadOak Capital on the board
- Biolog, Inc. /DE/$16.1M
- Flagship Biosciences, Inc.$5M
- LTS1, Inc.$2.5M
- Telesis Bio Inc.$28M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.